Skip to content

Neuropsychological Assessment of Children and Adolescents With Turner Syndrome

Neuropsychological Assessment of Children and Adolescents With Turner Syndrome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03812913
Acronym
ENEAST
Enrollment
70
Registered
2019-01-23
Start date
2019-09-05
Completion date
2025-12-05
Last updated
2024-12-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Turner Syndrome, Isolated Growth Hormone Deficiency, Cognitive Functions, Social Cognition, Pediatrics

Keywords

Turner syndrome, Cognitive Functions, Social Cognition, Pediatrics

Brief summary

Turner syndrome (TS) is a rare chromosomal disorder characterized by partial or complete loss of one of the X chromosomes that affects about one in every 2000 female babies born. These young patients described difficulties making friends, understanding others' emotions and intentions, and controlling their own emotions. Difficulties in these domains could led to social withdrawal, to reduced social skills and could have a significant impact on self esteem and mental health as well as on long-term academic and social functioning in affected individuals. The purpose of this project is to identify functional and dysfunctional cognitive and socio-cognitive abilities in these young patients which could account social difficulties described by some of them and their family. To this end, 35 girls with TS and 35 girls with isolated growth hormone deficiency and normal cerebral MRI will be recruited. Subjects will be 7 to 16 years and 11 months of age. Socio-cognitive and cognitive functions will be assessed with neuropsychological and experimental tasks. Questionnaires completed by patient, parents or teacher, will evaluate social and behavioral functioning.

Detailed description

Cross-sectional study (2 groups : Turner syndrome, isolated growth hormone deficiency), not randomized, controlled, associating several specialized centers in endocrine diseases. The pediatric endocrinologist of the participating centers will contact parents of each patient or voluntary child/adolescent in order to inform them of the study. The visit of inclusion will take place in the participant center during a routine monitoring visit. The first visit (V1) will take place immediately after the visit of inclusion in order to avoid a specific displacement for the needs for the study. The second visit (V2) will take place in participant's home. Each visit (V1 and V2) will last half-day. The period between V1 and V2 will be three months maximum. The visits V1 and V2 will be carried out by neuropsychologists of the Laboratoire de Psychologie des Pays de la Loire (LPPL - EA 4638).

Interventions

* Neuropsychological and experimental tasks will assess cognitive and socio-cognitive functions. * Questionnaires will assess psychoaffective aspects (depression, anxiety, self-esteem), and social and behavioral functioning.

Sponsors

University Hospital, Angers
Lead SponsorOTHER_GOV

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
7 Years to 16 Years
Healthy volunteers
No

Inclusion criteria

Turner syndrome group : * girls with diagnosed Turner syndrome. Isolated GHD group : * girls with diagnosed isolated growth hormone deficiency All participants : * age between 7 years to 16 years and 11 months. * informed consent signed by the participant and her parents (or her legal representatives) * being registered in the national social security system

Exclusion criteria

: Turner syndrome group : * patients with chronic pathology other than Turner syndrome. * karyotype : part of a Y chromosome and r(X) cases. * medical treatment other than those usually prescribed in patients with Turner syndrome. Isolated GHD group : * patients with chronic pathology other than isolated growth hormone deficiency. * medical treatment other than those usually prescribed in patients with isolated growth hormone deficiency. All participants : * diagnosed intellectual disability (IQ\<70) or intellectual giftedness * history of acquired brain injury * sensory disturbances (auditory or visual) incompatible with the achievement of neuropsychological tasks. * insufficient French language proficiency

Design outcomes

Primary

MeasureTime frameDescription
Alexithymia3 monthsQuestionnaire d'alexithymie chez l'enfant (QAE)
Empathy3 monthsInterpersonal Reactivity Index (IRI)
Cognitive theory of mind advanced3 monthsadvanced theory of mind tasks (Happé, 1994)
Cognitive theory of mind : humor3 monthsHumor understanding task
Affective theory of mind : faux pas3 monthsFaux pas recognition test (Baron Cohen et al., 1999)
Affective theory of mind : first order3 monthsFirst-order affective theory of mind tasks
Affective theory of mind : second order3 monthsSecond-order affective theory of mind tasks
Affective theory of mind : emotional inference3 monthsEmotional inference for context test
Emotional valence recognition : valence3 monthsEmotional valence rating from visual scenes
Facial emotion recogniton3 monthsFacial emotion recognition task
Vocal emotion recognition3 monthsEmotional prosody recognition task
Emotional regulation3 monthsEmotion Regulation Questionnaire for Children and Adolescents (ERQ-CA)
Wechsler Intelligence Scale for Children (WISC-V)3 monthsintelligence scale.
Cognitive theory of mind first order3 monthsFirst order theory of mind tasks (Baron-Cohen et al., 1985)
Cognitive theory of mind second order3 monthssecond-order theory of mind tasks Perner & Wimmer, 1983)
Oral Language comprehension abilities 13 monthsComprehension of Instructions (NEPSY-II, Korkman et al., 2012)
Oral Language comprehension abilities 23 monthsVerbal comprehension index (from WISC-V)
Visual and visual-spatial abilities:13 monthsArrows subtest (NEPSY-II - Korkman et al., 2012),
Visual and visual-spatial abilities:23 monthsPicture Puzzles subtest (NEPSY-II - Korkman et al., 2012)
Visual and visual-spatial abilities:33 monthsBenton Facial Recognition Test (Benton et al., 1983)
Executive abilities-Verbal Working memory 13 monthsVerbal information updating task
Executive abilities-Visuo-Spatial Working memory 23 monthsVisuo-spatial information updating task
Executive abilities-Inhibition 13 monthsStroop test.
Executive abilities-Inhibition 23 monthsTapping test
Executive abilities-Inhibition 33 monthsnon-verbal cancellation task
Executive abilities-Cognitive Flexibility 13 monthsVerbal fluency task (NEPSY-II Korkman et al., 2012)
Executive abilities-Cognitive Flexibility 23 monthsModified Wisconsin Card Sorting Test for children
Executive abilities-Cognitive Flexibility 33 monthsTrail Making Test
Executive abilities-Higher-order executive functions 13 monthsscript generation task
Executive abilities-Higher-order executive functions 23 monthsRey Complex Figure Test : Copy
Executive abilities in daily life3 monthsBehavioral Rating Inventory of Executive Functions
Self Esteem3 monthsRosenberg self-esteem scale (1965).
Depression inventory3 monthsDepression: Children's Depression Inventory (Kovacks & Beck, 1977).
Anxiety inventory3 monthsRevised Children's Manifest Anxiety Scale (Reynolds & Richmond, 1999).
Social desirability3 monthsChildren's Social Desirability Scale (Crandall et al., 1965)
social adjustment 13 monthsConners' Parent Rating Scale-Revised: Short Form (Conners, 1997)
social adjustment 23 monthsConners' Teacher Rating Scale-Revised: Short Form (Conners, 1997)
behavioral adjustment3 monthsChild Behavior Checklist (Achenbach, 1991).

Countries

France

Contacts

Primary ContactRégis Coutant, MD PhD
ReCoutant@chu-angers.fr33(02)41-35-56-55
Backup ContactEmmanuel Quemener, CRA
EmQuemener@chu-angers.fr33(02)41-35-45-81

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026